Current pathogenetic and molecular concepts in viral liver carcinogenesis.
Hepatocellular carcinoma (HCC) is one of the most frequent malignancies in humans and in most cases a consequence of chronic infection of the liver by hepatotropic viruses (Hepatitis B Virus (HBV) and possibly Hepatitis C Virus (HCV)). Formation of HCC results from a stepwise process involving different preneoplastic lesions that reflect multiple genetic events, like protooncogene activation, tumor suppressor gene inactivation, and growth factor over- or reexpression. Recent investigations have gained new insights into how these factors are activated and may interact. In addition, improved knowledge of the molecular biology of HBV has led to better understanding of its pleiotropic effects on induction and progression in hepatocarcinogenesis.
Schirmacher
P
P
Institute of Pathology, University Hospital, Mainz, Federal Republic of Germany.
Rogler
C E
CE
Dienes
H P
HP
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000473:pathology; D004195:Disease Models, Animal; D016147:Genes, Tumor Suppressor; D006133:Growth Substances / Q000502:physiology; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology* / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000209:etiology / Q000473:pathology; D011230:Precancerous Conditions / Q000209:etiology / Q000473:pathology; D011519:Proto-Oncogenes; D012307:Risk Factors
D006133:Growth Substances